All PKC inhibitors induced apoptosis in M-HCC cells and exhibited limited/no activity in E-HCC cells at tested conditions, suggesting their action represents class effect (Fig. 5 and Supplementary Figs. S3–4). Here, PRRT2 is linked to hepatocellular carcinoma.